1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Continuous Subcutaneous Insulin Infusion Market, by Product
6.1. Introduction
6.2. Patch Pumps
6.2.1. Basal
6.2.2. Basal and bolus
6.2.3. Bous
6.3. Tethered pumps
6.3.1. Battery
6.3.2. Insulin reservoir and cartridges
6.3.3. Insulin set insertion devices

7. Continuous Subcutaneous Insulin Infusion Market, by Patient Type
7.1. Introduction
7.2. Type 1 diabetes
7.3. Type 2 diabetes

8. Continuous Subcutaneous Insulin Infusion Market, by End-user
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Laboratory

9. California Continuous Subcutaneous Insulin Infusion Market

10. Florida Continuous Subcutaneous Insulin Infusion Market

11. Illinois Continuous Subcutaneous Insulin Infusion Market

12. New York Continuous Subcutaneous Insulin Infusion Market

13. Ohio Continuous Subcutaneous Insulin Infusion Market

14. Pennsylvania Continuous Subcutaneous Insulin Infusion Market

15. Texas Continuous Subcutaneous Insulin Infusion Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Apex Medical Corp.
17.2. Byram Healthcare Centers, Inc.
17.3. Cellenovo
17.4. Cellnovo Group
17.5. CeQur SA
17.6. Dana Diabecare RS
17.7. DEKA Research & Development Corporation
17.8. DexCom, Inc.
17.9. Edgepark
17.10. IA Collaborative Holdings, LLC
17.11. Kaleido
17.12. Medtronic plc
17.13. Medtrum Technologies Inc.
17.14. OpenAPS
17.15. Pumps It, Inc.
17.16. Roche Holding AG
17.17. Shanghai Microport Orthopedics
17.18. Tandem Diabetes Care, Inc.
17.19. Tidepool
17.20. Valeritus
17.21. Ypsomed Holding

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2027
FIGURE 6. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2020 VS 2027 (%)
FIGURE 23. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2027
FIGURE 25. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2020 VS 2027 (%)
FIGURE 30. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2020 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2027
FIGURE 32. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: FPNV POSITIONING MATRIX
FIGURE 39. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 40. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATCH PUMPS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BASAL AND BOLUS, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BOUS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TETHERED PUMPS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY BATTERY, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN RESERVOIR AND CARTRIDGES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY INSULIN SET INSERTION DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOMECARE, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY LABORATORY, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SCORES
TABLE 20. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: RANKING
TABLE 23. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET: LICENSE & PRICING

Companies Mentioned

Apex Medical Corp.
Byram Healthcare Centers, Inc.
Cellenovo
Cellnovo Group
CeQur SA
Dana Diabecare RS
DEKA Research & Development Corporation
DexCom, Inc.
Edgepark
IA Collaborative Holdings, LLC
Kaleido
Medtronic plc
Medtrum Technologies Inc.
OpenAPS
Pumps It, Inc.
Roche Holding AG
Shanghai Microport Orthopedics
Tandem Diabetes Care, Inc.
Tidepool
Valeritus
Ypsomed Holding